COPD Trial, Recruiting NCT07302425 Sponsor: Istituti Clinici Scientifici Maugeri SpA Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT07302425
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with COPD (a lung condition) confirmed by a specific breathing test result (FEV1/FVC below 70%), following recognised medical guidelines
  • People whose condition is currently stable, based on a blood measurement showing the body's acid-balance is within an acceptable range (pH above 7.30)
  • People who have been discharged from hospital within the last 3 weeks following a sudden worsening of their COPD symptoms
  • People who are able to complete a walking test (a standard 6-minute walk test used to measure physical ability)

Who may not be able to join:

  • People who have a lung disease other than COPD
  • People who have bone, joint, or nerve conditions that would prevent them from completing physical tests
  • People who have serious heart conditions, serious neurological (brain or nerve) conditions, or other serious illnesses that affect their ability to exercise
  • People who show signs of significant memory or thinking difficulties, based on a short cognitive assessment (a score below 25 on a standard memory and thinking test)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mara Paneroni, PhD, MSc, ICS Maugeri IRCCS, respiratory rehabilitation of the Institute of Lumezzane

Phone: +0039+030+8253

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istituti Clinici Scientifici Maugeri SpA
Registry
ClinicalTrials.gov
Start date
30 October 2025
Est. completion
1 October 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Dyspnea during daily activities measured by the Barthel Dyspnea Index (BDI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov